Prevention of infections by probiotics

Journal of Bioscience and Bioengineering

Volumn 100, Issue 6, 2005, Pages 583-592

  Nomoto, Koji ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

action mechanisms; acute diarrhea; neonatal infections; prebiotics; probiotics; surgical infections; synbiotics

Indexed keywords

BACTERIA; BIODIVERSITY; DISEASES; ESCHERICHIA COLI; FOOD PRODUCTS; IMMUNOLOGY;

ACTION MECHANISMS; ACUTE DIARRHEA; NEONATAL INFECTIONS; PREBIOTICS; PROBIOTICS; SYNBIOTICS;

BIOMEDICAL ENGINEERING;

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; CLARITHROMYCIN; GALACTOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; RABEPRAZOLE; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ACUTE DIARRHEA; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BILE DUCT RECONSTRUCTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; COLONY FORMING UNIT; DEHYDRATION; DRUG MECHANISM; EATING HABIT; ENTERIC FEEDING; ENTERITIS; ENTEROBACTER INFECTION; ENTEROCOCCUS FAECIUM; ENTEROHEMORRHAGIC ESCHERICHIA COLI; FLUID THERAPY; GASTROINTESTINAL SURGERY; GRAM NEGATIVE INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION; INFECTION PREVENTION; INTESTINE INFECTION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LIVER RESECTION; MYCOSIS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PERITONITIS; PNEUMONIA; POSTOPERATIVE INFECTION; SACCHAROMYCES BOULARDII; SALMONELLOSIS; SEXUALLY TRANSMITTED DISEASE; STAPHYLOCOCCUS; STREPTOCOCCUS THERMOPHILUS; TRAVELLER DIARRHEA; TREATMENT OUTCOME; UROGENITAL TRACT INFECTION; VAGINITIS; VIRUS INFECTION; WOUND INFECTION; ANIMAL; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; INFECTION CONTROL; METHODOLOGY; PREVENTIVE MEDICINE; REVIEW;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANIMALS; CLINICAL TRIALS; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; INFECTION CONTROL; PREVENTIVE MEDICINE; PROBIOTICS; TREATMENT OUTCOME;

EID: 33645514238     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.100.583     Document Type: Article

References (80)

1. Glass R.I., Lew J.F., Gangarosa R.E., LeBaron C.W., and Ho M.S. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J. Pediatr. 118 (1991) S27-S33
2. Fuller R. Robotics in man and animals. J. Appl. Bacteriol. 66 (1989) 365-378
3. Reid G. The importance of guidelines in the development and application of probiotics. Curr. Pharm. Des. 11 (2005) 11-16
4. Reid G., Jass J., Sebulsky M.T., and McCormick J.K. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 16 (2003) 658-672
5. Gill H.S. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol. 17 (2003) 755-773
6. Bengmark S. Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract. Res. Clin. Gastroenterol. 17 (2003) 833-848
7. Alvarez-Olmos M.I., and Oberhelman R.A. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis. 32 (2001) 1567-1576
8. de Roos N.M., and Katan M.B. Effect of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am. J. Clin. Nutr. 71 (2000) 405-411
9. Isolauri E., Juntunen M., Rautanen T., Sillanaukee P., and Koivula T. A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88 (1991) 90-97
10. Shornikova A.V., Casas I.A., Isolauri E., Mykkanen H., and Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr. 24 (1997) 399-404
11. Guandalini S., Pensabene L., Zikri M.A., Dias J.A., Casali L.G., Hoekstra H., Kolacek S., Massar K., Micetic-Turk D., Papadopoulou A., and other 4 authors. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European study. J. Pediatr. Gastroenterol. Nutr. 30 (2000) 54-60
12. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., and Yolken R.H. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344 (1994) 1046-1049
13. Mastretta E., Longo P., Laccisaglia A., Balbo L., Russo R., Mazzaccara A., and Gianino P. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J. Pediatr. Gastroenterol. Nutr. 35 (2002) 527-531
14. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., and Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 138 (2001) 361-365
15. Surawicz C.M., Elmer G.W., Speelman P., McFarland L.V., Chinn J., and van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii. A prospective study. Gastroenterology 96 (1989) 981-988
16. McFarland L.V., Surawicz C.M., Greenberg R.N., Elmer G.W., Moyer K.A., Melcher S.A., Bowen K.E., and Cox J.L. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 90 (1995) 439-448
17. Pant A.R., Graham S.M., Allen S.J., Harikul S., Sabchareon A., Cuevas L., and Hart C.A. Lactobacillus GG and acute diarrhoea in young children in the tropics. J. Trop. Pediatr. 42 (1996) 16-25
18. Colombel J.F., Cortot A., Neut C., and Romond C. Yogurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 2 (1987) 43
19. Buydens P., and Debeucklaere S. Efficacy of SF 68 in the treatment of acute diarrhea: a placebo controlled trial. Scand. J. Gastroenterol. 31 (1996) 887-891
20. D'Souza A.L., Rajkumar C., Cooke J., and Bulpitt C.J. Probiotics in prevention of antibiotic-associated diarrhoea: meta analysis. Brit. Med. J. 324 (2002) 1361-1364
21. DuPont H.L., and Ericsson C.D. Prevention and treatment of traveler's diarrhea. N. Engl. J. Med. 328 (1993) 1821-1827
22. Oksanen P.J., Salminen S., Saxelin M., Hamalainen P., Ihantola-Vormisto A., Muurasniemi-Isoviita L., Nikkari S., Oksanen T., Porsti I., Salminen E., and other 4 authors. Prevention of traveler's diarrhoea by Lactobacillus GG. Ann. Med. 22 (1990) 53-56
23. Katelaris P.H., Salam I., and Farthing M.J.G. Lactobacilli to prevent traveler's diarrhea?. N. Engl. J. Med. 333 (1995) 1360-1361
24. Lucas A., and Cole T.J. Breast milk and neonatal necrotizing enterocolitis. Lancet 336 (1990) 1519-1523
25. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Dis. 3 (1999) 197-202
26. Dani C., Biadaioli R., Bertini G., Martelli E., and Rubaltelli F.F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis, and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol. Neonate 82 (2002) 103-108
27. Millar M.R., Bacon C., Smith S.L., Walker V., and Hall M.A. Enteral feeding of premature infants with Lactobacillus sp. strain GG. Arch. Dis. Child. 69 (1993) 483-487
28. Kitajima H., Sumida Y., Tanaka R., Yuki N., Takayama H., and Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomized controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 76 (1997) F101-F107
29. Kanamori Y., Hashizume K., Sugiyama M., Morotomi M., and Yuki N. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Digest. Dis. Sci. 46 (2001) 2010-2016
30. Kanamori Y., Hashizume K., Sugiyama M., Mortomi M., Yuki N., and Tanaka R. A novel synbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (LTEC) in the intensive care unit. Clin. Nutr. 21 (2002) 527-530
31. Kanamori Y., Hashizume K., Kitano Y., Tanaka Y., Morotomi M., Yuki N., and Tanaka R. Anaerobic dominant flora was reconstructed by synbiotics in an infant with MRSA enteritis. Pediatr. Intern. 45 (2003) 359-362
32. Candy D.C., Densham L., Lamont L.S., Greig M., Lewis J., Bennett H., and Griffiths M. Effect of administration of Lactobacillus casei Shirota on sodium balance in an Infant with short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 32 (2001) 506-508
33. Hotta M., Sato Y., Iwata S., Yamashita N., Sunakawa K., Oikawa T., Tanaka R., Watanabe K., Takayama H., Yajima M., and other 4 authors. Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea. Keio J. Med. 36 (1987) 298-314
34. Tojo M., Oikawa T., Morikawa Y., Yamashita N., Iwata S., Satoh Y., Hanada J., and Tanaka R. The effects of Bifidobacterium breve administration on Campylobacter enteritis. Acta Paediatr. Jpn. 29 (1987) 160-167
35. Rayes N., Seehofer D., Hansen S., Boucsein K., Muller A.R., Serke S., Bengmark S., and Neuhaus P. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination; a controlled trial in liver transplant recipients. Transplantation 74 (2002) 123-127
36. Rayes N., Hansen S., Seehofer D., Muller A.R., Serke S., Bengmark S., and Neuhaus P. Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18 (2002) 609-615
37. Kanazawa H., Nagino M., Kamiya S., Komatsu S., Mayumi T., Takagi K., Asahara T., Nomoto K., Tanaka R., and Nimura Y. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch. Surg. 390 (2005) 104-113
38. Berg R.D., and Garlington A.W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect. Immun. 23 (1979) 403-411
39. Wiest R., and Rath H.C. Bacterial translocation in the gut. Best Pract. Res. Clin. Gastroenterol. 17 (2003) 397-425
40. Kabir A.M., Aiba Y., Takagi A., Kamiya S., Miwa T., and Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41 (1997) 49-55
41. Coconnier M.H., Lievin V., Hemery E., and Servin A.L. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64 (1998) 4573-4580
42. Midolo P.D., Lambert J.R., Hull R., Luo F., and Grayson M.L. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 79 (1995) 475-479
43. Sgouras D., Maragkoudakis P., Petraki K., Martinez-Gonzalez B., Eriotou E., Michopoulos S., Kalantzopoulos G., Tsakalidou E., and Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70 (2004) 518-526
44. Canducci F., Armuzzi A., Cremonini F., Cammarota G., Bartolozzi F., Pola P., Gasbarrini G., and Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment. Pharmacol. Ther. 14 (2000) 1625-1629
45. Felley C.P., Corthesy-Theulaz I., Rivero J.L., Sipponen P., Kaufmann M., Bauerfeind P., Wiesel P.H., Brassart D., Pfeifer A., Blum A.L., and Michetti P. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol. 13 (2001) 25-29
46. Michetti P., Dorta G., Wiesel P.H., Brassart D., Verdu E., Herranz M., Felley C., Porta N., Rouvet M., Blum A.L., and Corthesy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonni) La1 on Helicobacter pylori infection in humans. Digestion 60 (1999) 203-209
47. Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., and Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrobiol. Chemother. 47 (2001) 709-710
48. Reid G. Probiotic agents to protect the urogenital tract against infection. Am. J. Clin. Nutr. 73 (2001) 437S-444S
49. Hallen A., Jarstrand C., and Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex. Trans. Dis. 19 (1992) 146-148
50. Reid G., Bruce A.W., and Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol. Ther. 23 (1995) 32-45
51. Reid G., and Bruce A.W. Low vaginal pH and urinary-tract infection. Lancet 346 (1995) 1704
52. Reid G., Bruce A.W., and Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol. Ther. 23 (1995) 32-45
53. Reid G., Cook R.L., and Bruce A.W. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J. Urol. 138 (1987) 330-335
54. Reid G., and Bruce A.W. Selection of Lactobacillus strains for urogenital probiotic applications. J. Infect. Dis. 183 (2001) S77-S80
55. Asahara T., Nomoto K., Watanuki M., and Yokokura T. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob. Agents Chemother. 45 (2001) 1751-1760
56. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., and Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35 (2003) 131-134
57. Schwebke J.R. Role of vaginal flora as a barrier to HIV acquisition. Curr. Infect. Dis. Rep. 3 (2001) 152-155
58. Sewankambo N., Gray R.H., Wawer M.J., Paxton L., McNaim D., Wabwire-Mangen F., Serwadda D., Li C., Kiwanuka N., Hillier S.L., and other 4 authors. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350 (1997) 546-550
59. Asahara T., Nomoto K., Shimizu K., Watanuki M., and Tanaka R. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J. Appl. Microbiol. 91 (2001) 985-996
60. Asahara T., Shimizu K., Nomoto K., Tanaka R., Hamabata T., Ozawa A., and Takeda Y. Probiotic Bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72 (2004) 2240-2247
61. Nomoto K. Immunoregulatory functions of Probiotics. Biosci. Microflora 19 (2000) 1-8
62. Nomoto K., and Tanaka R. Immunoregulation by Probiotics. Jpn. J. Nutr. Assess. 16 (1999) 371-377
63. Miake S., Nomoto K., Yokokura T., Mutai M., and Nomoto K. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice. Infect. Immun. 48 (1985) 480-485
64. Yokokura T., Nomoto K., Shimizu T., and Nomoto K. Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei. Infect. Immun. 52 (1986) 156-160
65. Tsunoda A., Shibusawa M., Tsunoda Y., Watanabe M., Nomoto K., and Kusano M. Effect of Lactobacillus casei on a novel murine model of abdominal sepsis. J. Surg. Res. 107 (2002) 37-43
66. Ogawa M., Shimizu K., Nomoto K., Takahashi M., Watanuki M., Tanaka R., Tanaka T., Hamabata T., Yamasaki S., and Takeda Y. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect. Immun. 69 (2001) 1101-1108
67. de Waard R., Claassen E., Bokken G.C., Buiting B., Garssen J., and Vos J.G. Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion. Clin. Diagn. Lab. Immunol. 10 (2003) 59-65
68. de Waard R., Garssen J., Snel J., Bokken G.C., Sako T., Veld J.H., and Vos J.G. Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT 9029 in Wister and Brown rats. Clin. Diagn. Lab. Immunol. 8 (2001) 762-767
69. Lee Y.K., Lim C.Y., Teng W.L., Ouwehand A.C., Tuomola E.M., and Salminen S. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl. Environ. Microbiol. 66 (2000) 3692-3697
70. Gorbach S.L. Probiotics in the third millennium. Digest. Liver Dis. 34 (2002) S2-S7
71. Reid G. Importance of guidelines in the development and application of probiotics. Curr. Pharm. Des. 11 (2005) 11-16
72. Turchet P., Laurenzano M., Auboiron S., and Antoine J.M. Effect of fermented milk containing probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomized controlled pilot study. J. Nutr. Health Aging 7 (2003) 75-77
73. Mackay A.D., Taylor M.B., Kibbler C.C., and Hamilton-Miller J.M. Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect. 5 (1999) 290-292
74. Avlami A., Kordossis T., Vrizidis N., and Sipsas N.V. Lactobacillus rhamnosus endocarditis complicating colonoscopy. J. Infect. 42 (2001) 283-285
75. Land M.H., Rouster-Stevens K., Woods C.R., Cannon M.L., Cnota J., and Shetty A.K. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion?. Pediatrics 115 (2005) 178-181
76. Rautio M., Jousimies-Somer H., Kauma H., Pietarinen I., Saxelin M., Tynkkynen S., and Koskela M. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis. 28 (1999) 1159-1160
77. Salminen M.K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., and Jarvinen A. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 38 (2004) 62-69
78. Kunz A.N., Noel J.M., and Fairchok M.P. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J. Pediatr. Gastroenterol. Nutr. 38 (2004) 457-458
79. Pletinex M., Legein J., and Vandeplas Y. Fungicemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J. Pediatr. Gastroenterol. Nutr. 21 (1995) 113-115
80. Asahara T., Takahashi M., Nomoto K., Takayama H., Onoue M., Morotomi M., Tanaka R., Yokokura T., and Yamashita N. Assessment of safety of Lactobacillus strains based on resistance to host innate defense mechanisms. Clin. Diagn. Lab. Immunol. 10 (2003) 169-173